Please Wait...

George Edeburn

Main profile

George F. Edeburn, M.D.
George F. Edeburn, M.D.
Vice President Medical Affairs

Dr. Edeburn received his BA degree from the University of St. Thomas, his MD degree from the University of Minnesota School of Medicine, and his MPH. from the Harvard University School of Public Health. He completed his residency in Diagnostic Radiology at the University of Minnesota Affiliated Hospitals, and a fellowship in Nuclear Medicine at Harvard Medical School. Dr. Edeburn has also conducted research into multifocal osteomyelitis in children at St. Göran’s Children’s Hospital, Karonlinska Institute in Stockholm, Sweden.

Prior to joining BioClinica (formerly CoreLab Partners) in 2007, Dr. Edeburn has held appointments at Caritas Norwood and Caritas Southwood Hospitals in Massachusetts where he was the Director of Nuclear Medicine as well as with St. Paul Radiology in St. Paul, Minnesota. Dr. Edeburn has also served as a consultant and the Associate Director, Medical Affairs for Nycomed Amersham Imaging and the Associate Director, Corporate Medical Support for Bracco Diagnostics, Inc.

Dr. Edeburn has been board certified in Diagnostic Radiology with Special Competency in Nuclear Radiology since 1985 and is a member of professional organizations including the American College of Radiology, RSNA, DIA, the Society of Nuclear Medicine and the European Radiological Association.

With more than 20 years of clinical practice, Dr. Edeburn’s research interests include contrast media safety and efficacy as well as imaging of bone disorders, oncologic and cardiovascular disease.

LEARN MORE OR SPEAK WITH OUR EXPERTS

CONTACT US
Leader in Clinical Trial
Management Solutions

Successful clinical trials require the ability to see key details and uncover hidden insights. Bioclinica utilizes science and technology to bring clarity to clinical trials, helping companies to develop new life-improving therapies more efficiently and safely.

ASCPT 2018 Annual Meeting https://t.co/i0mjYbBq5N Join @Bioclinica Research's Open House 3/22 https://t.co/citlLotbD7
bioclinica (Yesterday)
Heading to DC for DIA's #Pharmacovigilance & Risk Mgmt Strategies Conf.? Visit @Bioclinica in booth 32. Preview our… https://t.co/alU1sCg04l
bioclinica (Yesterday)
Kevin Bishop, named a 'Top Innovator' in #clinicaltrials by @CenterWatch See how we're reducing risk to the clinic… https://t.co/rXBGvIh9Wr
bioclinica (2 days ago)
RT @CenterWatch: Congratulations to all our #2018TopInovators! Read about the innovations in the #CWMonthly special edition, https://t.co/Y…
bioclinica (1 week ago)
RT @CenterWatch: .@Pfizer demonstrates leadership in #clinicaltrial innovation with two spots on the @CenterWatch #2018TopInnovators, https…
bioclinica (1 week ago)
RT @jheanne: I just contributed towards 'Joby' on https://t.co/EHt69JFLZ9 Best wishes to Joby and all our @Bioclinica team members! @Oxfam…
bioclinica (1 week ago)

Latest Blogs:

Removing Risk from Clinical Trial Management System (CTMS) Implementations
Collaboration Between Clinical Operations and the Logistics and Supply Chain Teams is Key to Trial Success
The Value of Protocol Review
CTMS and RBM: Hot Topics at OCT Nordics in Copenhagen